Kulmus Genetics
Stealth Mode
Startup Pre-Seed Health Tech & Life Sciences Est. 2025
Total Raised
$50K
Pre-Seed
Last Round
$50K
1 rounds
Team
2
1-10 employees
Confidence
62/100
Patents
1
About
Kulmus Genetics Is Revolutionizing DNA Synthesis Synthetic DNA is essential for most synthetic biology applications. Kulmus Genetics is developing a high-throughput DNA synthesis solution for the rapidly growing synthetic biology field.
Classification
Sector
Health Tech & Life Sciences
Core Technology
Platforms & InterfacesBiologicalsMaterials & Substances
Target Customer
Healthcare & Life SciencesAgriculture & Food
Business Model
B2B
Tags
stealthmode
Funding & Events
Feb 2025
Pre-Seed $50K
Details
Product Stage
R&D
Employees
1-10
Exact Count
2
Founded
2025
Locations
Israel
Links
Website
Admin
Last Update
Oct 19, 2025
Verified by
Matan Eblagon
Claimed
Yes
Missing
sector, tags, description, video or image, news, markets, external profiles, not claimed
Team (2)
Rami Verbin
co-CEO
Founder
Shay Shilo
co-CEO
Founder
Internal
Created by
Matan Eblagon (matane@sncentral.org)
Created
2025-05-22T00:00:00.000Z